Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples